Intelligence · Clinical Pipeline
PTC THERAPEUTICS Pipeline
All ClinicalTrials.gov programs at PTC THERAPEUTICS — phase, modality, and trial IDs.
- Programs
- 12
Quick answer
PTC THERAPEUTICS has 12 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Ataluren
PTC THERAPEUTICS, INC.
Healthy
1 trial -
Deflazacort
PTC THERAPEUTICS, INC.
Healthy Volunteers
1 trial -
Deflazacort
PTC THERAPEUTICS, INC.
Hepatic Impairment
1 trial -
Deflazacort
PTC THERAPEUTICS, INC.
Renal Impairment
1 trial -
Deflazacort and rifampin
PTC THERAPEUTICS, INC.
Healthy Volunteers
1 trial -
PTC299
PTC THERAPEUTICS, INC.
Leukemia, Myeloid, Acute
1 trial -
PTC299
PTC THERAPEUTICS, INC.
Advanced Cancer
1 trial -
PTC299
PTC THERAPEUTICS, INC.
Metastatic Breast Cancer
1 trial -
PTC596
PTC THERAPEUTICS, INC.
Cancer
1 trial -
PTC596
PTC THERAPEUTICS, INC.
High Grade Glioma
1 trial -
Unesbulin
PTC THERAPEUTICS, INC.
Ovarian Cancer
1 trial -
VEGF inhibitor PTC299
PTC THERAPEUTICS, INC.
Brain and Central Nervous System Tumors
1 trial
Frequently asked questions
How many pipeline programs does PTC THERAPEUTICS have?
12 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs